product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
CNTF Antibody (001) [PE]
catalog :
NBP2-89998PE
quantity :
0.1 ml
price :
539 USD
clonality :
monoclonal
host :
domestic rabbit
conjugate :
PE
clone name :
001
reactivity :
human
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NBP2-89998PE
SKU :
NBP2-89998PE
product name :
CNTF Antibody (001) [PE]
sizes available :
0.1 ml
description :
The CNTF Antibody (001) [PE] from NBP2-89998PE is a 6.7e-05 antibody to . This antibody reacts with human.
target :
CNTF
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
001
conjugate :
PE
all_available conjugate :
PE
dilution :
ELISA
host :
Rabbit
immunogen :
This antibody was obtained from a rabbit immunized with purified, recombinant Human CNTF (Accession#: NP_000605.1; Ala 2-Met 200).
isotype :
IgG
purity :
Protein A purified
species :
Human
gene symbol :
CNTF
applications :
ELISA
extended description :
Recombinant Monoclonal Antibody
USD :
539 USD
product details :
Recombinant Monoclonal Antibody
alt names :
ciliary neurotrophic factor, HCNTF
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- Serpin E1/PAI-1 Antibody (004) [DyLight 405] | NBP2-89393V
- Serpin E1/PAI-1 Antibody (004) [DyLight 550] | NBP2-89393R
- TMEM156 Antibody [mFluor Violet 500 SE] | NBP3-06638MFV500
- Serpin E1/PAI-1 Antibody (004) [Alexa Fluor® 700] | NBP2-89393AF700
- Serpin E1/PAI-1 Antibody (004) [Alexa Fluor® 594] | NBP2-89393AF594
questions and comments
